METABOLOMICS SERVICES MARKET ANALYSIS

Metabolomics Services Market Size and Trends

The Global Metabolomics Services Market is estimated to be valued at USD 2.85 Billion in 2024 and is expected to reach USD 6.42 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.

Key Takeaways of the Metabolomics Services Market:

• Based on type of technique, the detection techniques segment is expected to contribute the highest share of the market with 52.1% in 2024
• Based on type of service, the targeted metabolomics segment is expected to contribute the highest share of the market with 42.3% in 2024
• Based on application, the drug discovery segment is expected to contribute the highest share of the metabolomics services market with a share of 37.2% in 2024
• North America is expected to top the global market with 39.3% share, followed by Asia Pacific with 25.7% share in 2024

Market Overview:

The increasing applications of metabolomics in personalized medicine, drug discovery and development, biomarker discovery, nutrigenomics, and other fields such as toxicology and cancer are contributing to the growth of this market. The metabolomics services market is witnessing high growth due to rising R&D investments in pharmaceutical and biotechnology companies. Metabolomics helps in understanding pathophysiological mechanisms, as well as in the screening of drug targets, which is driving its increasing adoption in drug discovery and development. Biomarker discovery using metabolomics also plays a vital role in personalized medicine by identifying metabolites that can be used to predict an individual’s response to drugs.

To learn more about this report, Request sample copy

Top Strategies Followed by Global Metabolomics Services Market Players

• Established Players: Leading companies in the global metabolomics services market heavily invest in extensive research and development to innovate high-performance products and solution. They focus on developing advanced technologies like AI-assisted metabolomics analysis tools, bioinformatics solutions for large-scale data processing capabilities.
  • For instance, Metabolon Inc. invested over US$ 25 million in R&D last year to launch new targeted and untargeted metabolomics profiling kits using mass spectrometry
• Mid-Level Players: Mid-sized players in the market strive to deliver quality metabolomics services and solutions at competitive prices to attract price-sensitive customers. They collaborate with research institutes and pharmaceutical companies on joint projects involving metabolomics studies of diseases. Such partnerships help mid-players gain technical expertise and industry exposure on a budget.
  • For example, Biocrates Life Sciences AG launched affordable metabolite profiling kits for academic researchers and biobanks
• Small-Scale Players: Emerging small players focus on specific disease areas or bodily fluids barely addressed by large vendors. They leverage cutting-edge technologies to efficiently process complex metabolomics data from niche samples.
  • For instance, Metabologist specializes in plant metabolomics using LC-MS and develops metabolites databases for crops and herbs

Emerging Startups - Metabolomics Services Industry Ecosystem

• Innovative Technologies: Startups are developing AI and machine learning tools to automate metabolite identification from metabolomics datasets. Companies like Metabrain focus on training neural networks on vast reference metabolite libraries to rapidly recognize unknown metabolites in biological samples. Such advanced technologies could help drive down costs and speed up metabolomics workflows.
• Sustainable Solutions: Some startups offer green chemistry approaches for sample preparation in metabolomics studies. Bioprofile develops enzymatic extraction kits that replace toxic organic solvents with cellulase enzymes, contributing to more sustainable metabolomics research. Their solutions help reduce hazardous waste generation in labs.
• Market Contribution: Emerging companies are entering niche segments often overlooked by established players. For instance, PhytoMetrix specializes in plant metabolomics, focusing on fruits, and provides comprehensive metabolite databases for specialty crops and orchards. Their metabolite identification services support research on niche fruits, aiding in the development of functional foods and enhancing crop quality.

Key Developments:

• On May 30, 2024, Metabolon, Inc., a leader in metabolomics solutions, introduced a 4-week turnaround for Global Discovery Panel projects of up to 2,000 samples, addressing the needs of commercial pharmaceutical markets. This enhancement supports faster R&D by providing timely insights from biological fluids like plasma, urine, and serum.
• On January 26, 2023, CosmosID, a leader in high-resolution microbiome analysis, introduced metabolomics services to support multi-omics research. Combining metagenomics, metatranscriptomics, and metabolomics, this approach offers detailed insights into microbial composition, gene expression, and metabolite production. The service aims to deliver actionable data for advancing microbiome research.
• In July 2021, Thermo Fisher Scientific, a global leader in serving science, offering innovative technologies, analytical instruments, and laboratory services, collaborated with University of California, U.S to establish the Center of Excellence in Clinical Metabolomics, advancing innovations and standardization in metabolomics research
• In April 2021, BioMérieux, a pioneer in in-vitro diagnostics, which specializes in microbiology, immunology, and molecular diagnostics, received CE Marking for VITEK MS PRIME, a cutting-edge MALDI-TOF mass spectrometry system for rapid microorganism identification, streamlining microbiology workflows